First published 9/30/2026, 12:18:15 AM · Last updated 9/30/2026, 12:18:30 AM

Natural products as selective estrogen receptor modulators in depression-related disorders: Balancing antidepressant efficacy and safety

Elsevier BV published a journal article on 2026-11-01 that examines natural products acting as selective estrogen receptor modulators for depression-related disorders and discusses balancing antidepressant efficacy with safety. The source record is metadata for a single peer-reviewed article and contains no further event details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article presents research relevant to development and safety assessment of potential antidepressant treatments.

Sources

Natural products as selective estrogen receptor modulators in depression-related disorders: Balancing antidepressant efficacy and safety

Report an issue